Auto-2T: Automated Analysis Algorithms in Second Trimester Obstetric Ultrasound

Sponsor
Università degli Studi di Brescia (Other)
Overall Status
Completed
CT.gov ID
NCT04441866
Collaborator
(none)
52
1
2
10.3
5

Study Details

Study Description

Brief Summary

This study aims to evaluate the effect of the use of automated algorithms for the measurement of fetal biometry, and for the reconstruction of standard planes of fetal anatomy, compared with the standard ultrasound technique, during the second trimester ultrasound scan.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Automated algorithms
  • Diagnostic Test: Standard technique
N/A

Detailed Description

In recent years in many ultrasound equipment were fitted with automated algorithms for measuring fetal biometry, and for the reconstruction of standard planes of fetal anatomy. Although there are studies that have assessed the application of these algorithms in terms of repeatability of the measurements made, or of possibility of acquiring diagnostic planes, there are no randomized controlled studies that evaluated their impact on the second trimester ultrasound scan.

The aim of the study is to evaluate the effect of the use of automated algorithms for the measurement of fetal biometry, and for the reconstruction of standard planes of fetal anatomy, compared with the standard ultrasound technique, in terms of:

  • duration of the ultrasound scan

  • quality of biometric measurements

  • quality of the diagnostic planes

  • operator satisfaction

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Automated Analysis Algorithms in Second Trimester Obstetric Ultrasound
Actual Study Start Date :
Jun 19, 2020
Actual Primary Completion Date :
Sep 30, 2020
Actual Study Completion Date :
Apr 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Automated algorithms

Automated 3D techniques in measuring fetal biometry and reconstructing standard anatomical planes

Diagnostic Test: Automated algorithms
Automated algorithms for measuring fetal biometry, and for the reconstruction of standard planes of fetal anatomy

Placebo Comparator: Standard technique

Standard 2D assessment

Diagnostic Test: Standard technique
Standard ultrasound examination without use of automated algorithms for measuring fetal biometry, and for the reconstruction of standard planes of fetal anatomy

Outcome Measures

Primary Outcome Measures

  1. Duration of ultrasound examination [During ultrasound examination]

    Duration of ultrasound examination in minutes

Secondary Outcome Measures

  1. Quality score of fetal biometry [During ultrasound examination]

    Score described by Salomon et al. 2006: range from 0 (worst) to 16 (best)

  2. Quality score of fetal diagnostic planes [During ultrasound examination]

    Score described by Salomon et al. 2008: range from 0 (worst) to 32 (best)

  3. Operator satisfaction [During ultrasound examination]

    Visual analogue scale: from 0 (worst) to 32 (best)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Singleton pregnancy 19+0-21+6 weeks

  • Live fetus

  • No fetal abnormalities

Exclusion Criteria:
  • Multiple pregnancy

  • Intrauterine fetal death

  • Fetal abnormalities

Contacts and Locations

Locations

Site City State Country Postal Code
1 Spedali Ciivli Brescia Italy

Sponsors and Collaborators

  • Università degli Studi di Brescia

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Federico Prefumo, Associate Professor, Università degli Studi di Brescia
ClinicalTrials.gov Identifier:
NCT04441866
Other Study ID Numbers:
  • NP3574
First Posted:
Jun 22, 2020
Last Update Posted:
Jun 14, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 14, 2021